Ole Andreas Halvorsen
CEO at VIKING GLOBAL INVESTORS
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (28)
Key Relationships
Sort
Motif Ingredients
Viking Global Investors
£75m
2 dealmakers
Affinivax
£97m
16 dealmakers
RALLYBIO
Pivotal Bioventure Partners
£119m
28 dealmakers
Ginkgo Bioworks
General Atlantic
£396m
6 dealmakers
Talkdesk
Threshold Ventures
£112m
9 dealmakers
Kinnate Biopharma
Nextech Invest
£74m
Velosbio
Cormorant Asset Management
£105m
LIANBIO
Logos Capital
£239m
18 dealmakers
4d Molecular Therapeutics
Mirae Asset Financial Group
£56m
11 dealmakers
Color Genomics
T. Rowe Price Group
£122m
7 dealmakers
Day One Biopharmaceuticals
Ra Capital Management
£94m
DRUVA
Atreides Management
Icosavax
Sanofi Ventures
£71m
19 dealmakers
Baillie Gifford & Co
£10,641m
107 dealmakers
CLIP
£176m
3 dealmakers
Procept Biorobotics Corp
Fidelity Management & Research Company
£61m
8 dealmakers
Arctic Wolf
Owl Rock Capital Partners
£108m
4 dealmakers
£166m
12 dealmakers
Apeel Sciences
DISRUPTIVE
£180m
ALPHASENSE
Goldman Sachs Asset Management
£133m
Global Processing Services
Advent International Corporation
£220m
14 dealmakers
£292m
10 dealmakers
FLUIDIGM
Casdin Capital
£184m
23 dealmakers
£186m
ID.ME
WNDRCO
£87m
£80m
5 dealmakers
Valsoft Corporation
Coatue Management
£510m
15 dealmakers